Active, Not Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06713239

A Randomized Comparison of Personalized Management for Medical and Interventional Therapy Based On Coronary Atherosclerotic Plaque Versus Usual Care for Symptomatic Patients With Suspicion of CAD

Led by Cleerly, Inc. · Updated on 2026-06-05

1000

Participants Needed

21

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

PARAMOUNT is a prospective randomized open-label trial testing the hypothesis that a personalized management strategy in symptomatic patients with suspicion of coronary artery disease (CAD), using a CT-based coronary atherosclerotic plaque assessment by AI-enabled quantitative software improves: certainty for diagnosis of CAD, control of CAD risk factors and efficiency of ICA referral with appropriate PCI compared to the usual care strategy based on current AHA/ACC guidelines for care of symptomatic patients with suspicion of CAD.

CONDITIONS

Brief Title

A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • > 18 years
  • Symptomatic patients with suspicion of CAD, including those referred for elective, non-urgent diagnostic testing (e.g. stress test)
Not Eligible

You will not qualify if you...

  • LDL < 100 mg/dL
  • Currently or previously treated beyond primary prevention guidelines
  • Suspected acute coronary syndrome or otherwise unstable clinical status
  • Planned cardiovascular procedure (e.g. coronary angiography, cardiac surgery, non-coronary vascular procedure)
  • Noninvasive or invasive CV testing for CAD within 1 year (e.g. invasive coronary angiography (ICA), coronary CT angiography (CCTA) including calcium scoring)
  • Known history of obstructive CAD (prior myocardial infarction, CABG or PCI, stenosis ≥50%)
  • Known EF ≤40% or other moderate to severe valvular or congenital cardiac disease
  • Contraindications to CCTA

Trial Site Locations

Total: 21 locations

1

Cardiology Associates of Mobile

Mobile, Alabama, United States, 36608

Status Unknown

2

Valiance Clinical Research- Huntington Park

Huntington Park, California, United States, 90255

Status Unknown

3

Cardiovascular Institute of San Diego

San Diego, California, United States, 91911

Status Unknown

4

Valiance Clinical Research- Tarzana

Tarzana, California, United States, 91356

Status Unknown

5

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Torrance, California, United States, 90502

Status Unknown

6

Intermountain Health Saint Joseph Hospital

Broomfield, Colorado, United States, 80021

Status Unknown

7

Tampa Cardiovascular Interventions and Research

Tampa, Florida, United States, 33614

Status Unknown

8

Flourish Research

Winter Park, Florida, United States, 32789

Status Unknown

9

Endeavor Health Clinical Operations

Evanston, Illinois, United States, 60201

Status Unknown

10

MercyOne Des Moines Medical Center

West Des Moines, Iowa, United States, 50266

Status Unknown

11

Saint Elizabeth Medical Center

Edgewood, Kentucky, United States, 41017

Status Unknown

12

Tulane University

New Orleans, Louisiana, United States, 70112

Status Unknown

13

Flourish- Bowie

Bowie, Maryland, United States, 20715

Status Unknown

14

St. Louis Heart and Vascular

Bridgeton, Missouri, United States, 63044

Status Unknown

15

Advanced Heart and Vascular Institute of Hunterdon

Flemington, New Jersey, United States, 08822

Status Unknown

16

Capital Cardiology Associates

Albany, New York, United States, 12211

Status Unknown

17

University of Cincinnatti

Cincinnati, Ohio, United States, 45221

Status Unknown

18

Oklahoma Cardiovascular Research Group

Oklahoma City, Oklahoma, United States, 73120

Status Unknown

19

The University of Tennessee Medical Center

Knoxville, Tennessee, United States, 37920

Status Unknown

20

Medical City Fort Worth Hospital

Fort Worth, Texas, United States, 76104

Status Unknown

21

Chippenham and Johnston Willis Hospitals

Richmond, Virginia, United States, 23225

Status Unknown

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

DIAGNOSTIC

Number of Arms

2

Similar Trials

24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Elut...

Elevated Lipoprotein(a) Level

Actively Recruiting

1 location

A 10-Minute Cardiovascular Magnetic Resonance Protocol for C...

Coronary Artery Disease

Actively Recruiting

1 location

A Danish Study to Assess the Efficacy of Implantable Cardiov...

Coronary Artery Disease

Actively Recruiting

1 location

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here